Share This

Public company info - China Shineway Pharmaceutical Group Ltd. , 02877.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

China Shineway Pharmaceutical Group Ltd., 02877.HK - Cash Flow 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12 2005-12
Net Cash Flow from Operating Activities 525,500 672,956 633,847 835,347 917,205 939,302 676,355 790,571 710,293 716,008 1,165,118 508,804 463,218 458,539 463,689
Net Cash Flow from Return on Investments & Servicing of Finance -170,229 -175,264 -155,204 -210,515 -237,676 -241,379 -218,569 -287,720 -271,217 -261,923 -143,285 -282,903 -153,565 -146,606 -71,597
　Interest Received 80,868 85,921 109,436 54,125 35,453 48,623 46,071 18,270 59,583 52,337 38,655 47,897 36,645 35,334 17,817
　Interest Paid -2,025 0 0 0 -219 -17,092 0 0 0 0 0 0 0 0 0
　Dividend Received 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Dividend Paid -249,072 -261,185 -264,640 -264,640 -272,910 -272,910 -264,640 -305,990 -330,800 -314,260 -181,940 -330,800 -190,210 -181,940 -89,414
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -157,504 -140,370 -143,201 -101,821 -172,498 -166,144 -156,469 -154,898 -225,231 -136,583 -107,798 -103,524 -61,248 -41,130 -6,043
Net Cash Flow from Investing Activities -11,325 27,019 -24,984 -133,831 -164,679 179,467 -721,805 -308,374 -387,819 -288,983 -306,843 -83,387 -90,153 -24,387 -153,790
　Additions to Fixed Assets -88,402 -139,797 -91,825 -106,792 -121,350 -104,177 -261,886 -368,876 -396,578 -368,790 -220,917 -84,156 -92,615 -23,219 -73,054
　Disposal of Fixed Assets 319 651 1,786 845 5,097 180 295 0 0 0 783 169 0 314 110
　Increase in Investments -900,000 -415,800 0 -78,360 -301,072 -7,951 0 -16,720 -163,280 -54,579 0 0 0 0 -80,846
　Decrease in Investments 936,511 470,507 47,975 -2,298 0 0 16,730 0 154,755 0 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 600 0 0 0 0 0 0
　Others 40,247 111,458 17,080 52,774 252,646 291,415 -476,944 77,222 16,684 134,386 -86,709 600 2,462 -1,482 0
Net Cash Flow before Financing Activities 186,442 384,341 310,458 389,180 342,352 711,246 -420,488 39,579 -173,974 28,519 607,192 38,990 158,252 246,416 232,259
Net Cash Flow from Financing Activities 145,788 -304,256 0 0 -200,600 -315,000 500,000 0 600 0 0 0 0 0 -10,178
　New Loans 398,392 0 0 0 0 200,000 500,000 0 0 0 0 0 0 0 0
　Loans Repayment -3,967 0 0 0 -200,000 -515,000 0 0 0 0 0 0 0 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 600 0 0 0 0 0 0
　Others -248,637 -304,256 0 0 -600 0 0 0 0 0 0 0 0 0 -10,178
Increase(Decrease) in Cash & Cash Equivalents 332,230 80,085 310,458 389,180 141,752 396,246 79,512 39,579 -173,374 28,519 607,192 38,990 158,252 246,416 222,081
Cash & Cash Equivalents at Beginning of Year 3,611,485 3,532,385 3,218,401 2,826,219 2,688,148 2,291,905 2,212,391 2,172,812 2,349,021 2,318,189 1,585,644 1,678,442 1,582,014 1,347,605 1,146,592
Net Cash Flow due to Change in Exchange Rate/Others 2,291 -985 3,526 3,002 -3,681 -3 2 0 -2,835 2,313 125,353 -131,788 -61,824 -12,007 -21,068
Cash & Cash Equivalents at End of Year 3,946,006 3,611,485 3,532,385 3,218,401 2,826,219 2,688,148 2,291,905 2,212,391 2,172,812 2,349,021 2,318,189 1,585,644 1,678,442 1,582,014 1,347,605
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.